Functional screening of FGFR4-driven tumorigenesis identifies PI3K/mTOR inhibition as a therapeutic strategy in rhabdomyosarcoma
Timothy McKinnon(Mount Sinai Hospital), Rebecca A. Gladdy(Princess Margaret Cancer Centre), Jack F. Shern(National Institutes of Health), Leah Kabaroff(Mount Sinai Hospital), Sivasish Sindiri(National Institutes of Health), Craig J. Thomas(National Institutes of Health), Guillaume Chouinard-Pelletier(Mount Sinai Hospital), Javed Khan(Kent State University), Marielle E. Yohe(National Cancer Center), Abha A. Gupta(Roche (Switzerland)), Serena Menezes(Mount Sinai Hospital), Krista Schleicher(Mount Sinai Hospital), Dariush Davani, Brendan C. Dickson(Sinai Health System), Cynthia J. Guidos(University of Toronto), Berkley E. Gryder(University School), Xiaohu Zhang(Soochow University), Yuhong Wei(McGill University), Rosemarie E. Venier(University of Toronto), Rajarashi Guha(National Center for Advancing Translational Sciences), Marc Ferrer(National Institute of Biomedical Innovation, Health and Nutrition)
Cited by 51
Related Papers
Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks
|Nature Medicine|2001|2.7k
Comprehensive Genomic Analysis of Rhabdomyosarcoma Reveals a Landscape of Alterations Affecting a Common Genetic Axis in Fusion-Positive and Fusion-Negative Tumors
|Cancer Discovery|2014|789
Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome
|Blood|2011|638
Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations
|Nature Genetics|2015|563